Clinical trial
Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam
NCT03537196 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 13, 2018
- Completion date
- December 30, 2022
- Enrollment
- 979 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
drug use, hepatitis c, viral hepatitis c